Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/VIVESTO-AB-30049569/nieuws/Vivesto-AB-meldt-positieve-preklinische-gegevens-die-de-verdere-ontwikkeling-van-Cantrixil-ondersteu-45630517/?utm_source=whatsapp&utm_medium=social&utm_campaign=share